A BMJ paper has shown that progress is being made on clinical trial transparency, although there is still a way to go.
BeiGene is adding Medidata’s electronic patient-reported outcome solution to oncology clinical studies.
Takeda inked a multiyear, $170 million-per-program drug discovery partnership with Schrödinger.
Sarepta offers Exondys 51 outside of the U.S. through a managed access program run by Clinigen, as an EMA decision is expected next year.
GB Sciences will soon start human testing of three cannabis-derived formulations for Parkinson's, chronic pain and cardiovascular diseases.
SynteractHCR has hired Steve Powell, who has years of experience on electronic data as a senior executive at Exco InTouch and PRA Health Sciences.
Medidata is making new conquests in the clinical trial world, as it just inked a deal to manage site payments for Worldwide Clinical Trials.
A proof-of-concept study suggests that combines AI and the whole-genome sequencing of tumors could scale precision medicine for cancer.
Private equity firm EQT is acquiring Certara from Arsenal Capital Partners, a deal that values the CRO at $850 million, Arsenal announced on Tuesday.
Science Exchange will offer IndieBio-backed biotech startups access to its outsourced R&D platform.